Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma
about
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis.Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
P2860
Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Application of a patient-deriv ...... y for nasopharyngeal carcinoma
@ast
Application of a patient-deriv ...... y for nasopharyngeal carcinoma
@en
type
label
Application of a patient-deriv ...... y for nasopharyngeal carcinoma
@ast
Application of a patient-deriv ...... y for nasopharyngeal carcinoma
@en
prefLabel
Application of a patient-deriv ...... y for nasopharyngeal carcinoma
@ast
Application of a patient-deriv ...... y for nasopharyngeal carcinoma
@en
P2093
P2860
P356
P1433
P1476
Application of a patient-deriv ...... y for nasopharyngeal carcinoma
@en
P2093
An-Chi Lin
Cheng-Lung Hsu
Chia-Hsun Hsieh
Hsien-Chi Fan
Hsin-Pai Li
Hung-Ming Wang
Kai-Ping Chang
Kar-Wai Lui
Tung-Liang Lin
P2860
P304
31323-31334
P356
10.18632/ONCOTARGET.5544
P407
P577
2015-09-24T00:00:00Z